Arlington Strengthens Healthcare Portfolio With TEAM Tech Acquisition

Arlington Capital Partners, a private investment company based near Washington, D.C., has announced its acquisition of TEAM Technologies, Inc. from Clearlake Capital Group. TEAM Technologies is a global leader in manufacturing essential healthcare products, offering specialised manufacturing and supply chain solutions to top-tier healthcare clients. 

The company supports medical device and pharmaceutical manufacturers by providing end-to-end design and production services, focusing on advanced medical devices crucial to healthcare operations. TEAM Tech operates over nine manufacturing facilities in the U.S., Mexico, and Singapore, with around 1 million square feet of manufacturing space.

Matt Altman, a Managing Partner at Arlington Capital Partners, said in a statement, “As the last five years have demonstrated, global supply chains are not nearly as fortified as they need to be, particularly in medical device manufacturing. TEAM Tech is not only focused on providing the world’s leading healthcare OEMs with holistic solutions for all their design and manufacturing needs but also on strengthening our healthcare supply chains to improve the delivery of these critical goods to end users.” 

Arlington Capital Partners has a strong record of investing in regulated healthcare industries, particularly companies that enhance patient care, improve supply chain efficiencies, and reduce costs. Its recent healthcare investments include Afton Scientific, AVS Bio, Millstone Medical Outsourcing, Riverpoint Medical, and Grand River Aseptic Manufacturing.

Gordon Auduong, an Arlington Principal, commented,  “As one of the leading end-to-end providers in this sector, we look forward to working with TEAM Tech’s management team and building on its strong foundation to continue adding capabilities and customers, both through organic investment and strategic acquisitions.”

Harris Williams served as TEAM Technologies’ financial advisor. The legal counsel was provided by Kirkland & Ellis LLP and Massumi + Consoli. Goodwin Procter LLP served as legal advisor on Arlington's side, with financial advisory services from R.W. Baird.

Marshall White, CEO of TEAM Tech, also added, “The medical device manufacturing industry is incredibly complex, but we feel fortunate to partner with Arlington in our next chapter. I have gotten to know Matt and the Arlington team well over the past several years and believe that with their 25 years of experience in this highly regulated sector, they are best positioned to help us build on the successes we have achieved and accelerate our growth, both organically and through strategic acquisitions, to take our business to the next level.”